Acriflavine, a potent inhibitor of HIF-1α, disturbs glucose metabolism and suppresses ATF4-protective pathways in melanoma under non-hypoxic conditions (Cancers, 2020)

(untitled) - Martí-Díaz, R; Montenegro, MF; Cabezas-Herrera, J; Goding, CR; Rodríguez-López, JN; Sánchez-del-Campo, L